Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-N Vacheron

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 16, 1999
Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophanN Aymard, A Viala, C Baldacci, et al.
Therapie|May 1, 1997
Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levelsN Aymard, C Baldacci, A Leyris, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 15, 2006
Motor threshold in transcranial magnetic stimulation: comparison of three estimation methodsC Tranulis, B Guéguen, A Pham-Scottez, et al.
The Pharmacogenomics Journal|June 10, 2010
Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophreniaF Mouaffak, O Kebir, M Chayet, et al.
L'Encephale|March 3, 2012
[RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]F-R Cousin, J-C Samuelian, M Saoud, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 16, 1999
Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophanN Aymard, A Viala, C Baldacci, et al.
Therapie|May 1, 1997
Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levelsN Aymard, C Baldacci, A Leyris, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 15, 2006
Motor threshold in transcranial magnetic stimulation: comparison of three estimation methodsC Tranulis, B Guéguen, A Pham-Scottez, et al.
The Pharmacogenomics Journal|June 10, 2010
Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophreniaF Mouaffak, O Kebir, M Chayet, et al.
L'Encephale|March 3, 2012
[RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice]F-R Cousin, J-C Samuelian, M Saoud, et al.
Pageof 2